Hypertrophic cardiomyopathy, commonly shortened to HCM, is a disease in which areas of the heart muscle become abnormally thick. That description sounds simple, but HCM is anything but one-size-fits-all. One person may experience breathlessness while walking upstairs, another may notice occasional heart palpitations, and someone else may have no symptoms whatsoever.
Although HCM can be serious, an early diagnosis, individualized risk assessment, regular monitoring, and modern treatment can help many people live active, fulfilling lives. The key is understanding what the condition does, recognizing warning signs, and treating the heart as an important teammate rather than an appliance that should work forever without maintenance.
What Is Hypertrophic Cardiomyopathy?
HCM is a form of cardiomyopathy, meaning a disease of the heart muscle. In most cases, the thickening affects the left ventricle, the chamber responsible for pumping oxygen-rich blood to the body. The wall separating the heart’s two lower chambers, called the interventricular septum, is frequently involved.
A thicker heart muscle is not necessarily a stronger one. In HCM, the enlarged muscle may become stiff, leaving the ventricle less able to relax and fill with blood between beats. The thickened tissue can also reduce the space inside the chamber, interfere with the mitral valve, disrupt electrical signals, or partially block blood leaving the heart. Essentially, the heart may have more muscle but less room to do its job.
Obstructive HCM
In obstructive hypertrophic cardiomyopathy, thickened muscle narrows the pathway through which blood exits the left ventricle. This pathway is called the left ventricular outflow tract. The obstruction may be present while a person is resting, or it may appear only during exercise, dehydration, or other conditions that make the heart contract more forcefully.
Nonobstructive HCM
Nonobstructive HCM does not create a major blockage at the outflow tract. However, the thickened and stiff heart muscle may still interfere with filling, increase pressure inside the heart, contribute to abnormal rhythms, and cause symptoms such as fatigue or shortness of breath. “Nonobstructive” does not mean “nonexistent” or “never needs follow-up.”
What Causes HCM?
Hypertrophic cardiomyopathy is often caused by a harmful change in a gene that provides instructions for proteins in the cardiac sarcomere, the microscopic machinery responsible for heart-muscle contraction. Changes involving genes such as MYH7 and MYBPC3 are among the better-known causes.
HCM commonly follows an autosomal dominant inheritance pattern. This means that a child of a parent carrying a disease-causing genetic variant may have a 50% chance of inheriting that variant. Inheriting it does not reliably predict when symptoms will begin, how thick the heart will become, or whether serious complications will occur. Even relatives with the same variant can have very different experiences. Genetics, apparently, enjoys keeping cardiologists humble.
Not every person with clinically diagnosed HCM receives a positive genetic test. Current tests do not identify every possible disease-causing change. Doctors must also rule out other explanations for heart-muscle thickening, including long-standing high blood pressure, aortic valve disease, certain metabolic disorders, infiltrative diseases, kidney disease, and the normal remodeling sometimes seen in highly trained athletes.
Symptoms of Hypertrophic Cardiomyopathy
Many people with HCM have few or no noticeable symptoms. Others experience symptoms only during physical exertion, after a heavy meal, in hot weather, during emotional stress, or when dehydrated. Symptoms may develop gradually, so a person might unconsciously slow down and assume that fatigue is simply part of getting older.
Common HCM Symptoms
- Shortness of breath, particularly during physical activity
- Chest pain or pressure, especially with exertion
- Fatigue or reduced exercise tolerance
- A racing, fluttering, pounding, or irregular heartbeat
- Dizziness or lightheadedness
- Fainting or nearly fainting
- Swelling in the legs, feet, or abdomen in more advanced disease
- A heart murmur discovered during a medical examination
These symptoms can have many causes, so experiencing one does not automatically mean a person has HCM. However, exertional fainting, unexplained chest pain, or a family history of HCM or sudden cardiac death deserves prompt medical evaluation.
When Symptoms Require Emergency Care
Call 911 for severe or persistent chest pain, sudden collapse, major difficulty breathing, or palpitations accompanied by fainting, confusion, or significant weakness. A person who becomes unresponsive and is not breathing normally may be experiencing cardiac arrest. Immediate CPR and use of an automated external defibrillator, when available, can be lifesaving.
How Is HCM Diagnosed?
Diagnosing hypertrophic cardiomyopathy usually begins with a detailed personal history, a physical examination, and a three-generation family history. The clinician may ask about fainting, exercise intolerance, abnormal heart rhythms, relatives with HCM, implanted defibrillators, heart failure, or unexplained sudden death at a young age.
Echocardiogram
A transthoracic echocardiogram uses ultrasound to show the heart’s structure, wall thickness, valves, pumping function, filling pattern, and blood-flow velocity. It can identify obstruction in the left ventricular outflow tract. If no significant blockage is present at rest, the clinician may use standing, the Valsalva maneuver, or exercise to determine whether an obstruction appears under stress.
Electrocardiogram and Rhythm Monitoring
An electrocardiogram records the heart’s electrical activity. Portable monitors may record rhythms for one or more days, while longer-term monitors may be used when symptoms are infrequent. These tests can uncover atrial fibrillation, nonsustained ventricular tachycardia, or other rhythm disturbances that influence treatment and sudden-death risk assessment.
Cardiac MRI
Cardiac magnetic resonance imaging provides detailed pictures of the heart muscle. It can clarify the location and extent of thickening, detect an apical aneurysm, identify areas of scar tissue, distinguish HCM from certain look-alike conditions, and contribute to decisions about an implantable cardioverter-defibrillator.
Exercise Testing and Genetic Evaluation
Exercise testing helps doctors evaluate blood-pressure response, functional capacity, symptoms, and obstruction that appears only with exertion. Genetic counseling can explain the advantages, limits, and possible family implications of genetic testing before a blood or saliva sample is analyzed.
Possible Complications
The course of HCM varies widely. Many people remain stable for years, while others develop complications that require active treatment. Regular follow-up matters because risk can change over time.
Abnormal Heart Rhythms
Atrial fibrillation can cause rapid or irregular heartbeats and may significantly increase stroke risk in people with HCM. Current guidance generally recommends systemic anticoagulation for clinical atrial fibrillation, regardless of the usual CHA2DS2-VASc score. Ventricular arrhythmias are less common but may lead to fainting, cardiac arrest, or sudden cardiac death.
Heart Failure
Heart failure does not mean the heart has stopped. In HCM, symptoms may result from impaired relaxation and filling even when the ejection fraction appears normal. A smaller percentage of patients eventually develops reduced pumping function or severe advanced heart failure.
Sudden Cardiac Death
Sudden cardiac death is a frightening but uncommon complication. Risk is not identical for everyone with HCM. Doctors evaluate factors such as previous cardiac arrest, sustained ventricular arrhythmia, unexplained fainting suspected to be arrhythmic, family history of premature sudden death, extreme wall thickness, an apical aneurysm, reduced ejection fraction, scar burden, and nonsustained ventricular tachycardia.
Risk assessment should be revisited periodically rather than treated like a lifetime weather forecast made during one appointment.
Treatment for Hypertrophic Cardiomyopathy
There is no single treatment plan for every person with HCM. Care depends on symptoms, the presence and severity of obstruction, heart rhythm, age, pregnancy plans, other medical conditions, and individual risk factors. People facing complex decisions may benefit from evaluation at a multidisciplinary HCM center.
Traditional Medications
For symptomatic obstructive HCM, nonvasodilating beta-blockers are commonly used first. They slow the heart rate, reduce the force of contraction, and give the ventricle more time to fill. If beta-blockers are ineffective or poorly tolerated, verapamil or diltiazem may be considered in appropriate patients.
Disopyramide may be added for persistent obstructive symptoms in selected individuals. Diuretics may help certain patients with fluid congestion, but they must be used cautiously because excessive fluid reduction can worsen an outflow obstruction. Medication choices should be supervised by a clinician familiar with the person’s HCM anatomy and physiology.
Cardiac Myosin Inhibitors
Cardiac myosin inhibitors reduce excessive interaction between proteins involved in heart-muscle contraction. Mavacamten, sold under the brand name Camzyos, was approved by the U.S. Food and Drug Administration in 2022 for certain adults with symptomatic obstructive HCM.
In December 2025, the FDA approved aficamten, sold under the brand name Myqorzo, for adults with symptomatic obstructive HCM to improve functional capacity and symptoms. These medications can reduce obstruction and improve how some patients feel, but they can also weaken heart contraction too much and cause heart failure. Echocardiographic monitoring, drug-interaction review, and participation in required safety programs are therefore essential. These are precision tools, not medications to borrow from someone whose prescription happens to be sitting nearby.
Septal Myectomy
Septal myectomy is open-heart surgery in which an experienced surgeon removes a carefully measured portion of thickened septal muscle. This widens the outflow tract and may also allow correction of associated mitral-valve abnormalities. It can provide substantial symptom relief for appropriately selected patients whose obstruction remains severe despite medication.
Alcohol Septal Ablation
Alcohol septal ablation is a catheter-based procedure that delivers a small amount of alcohol into a selected coronary artery branch. This intentionally creates a controlled area of damage, causing the obstructing muscle to shrink over time. It may be considered when surgery is not appropriate or when individual anatomy and preferences favor the catheter-based approach.
Both procedures require careful patient selection and should be performed by teams with extensive HCM experience. This is not an ideal occasion for a medical center to announce, “We have watched several excellent videos.”
Implantable Cardioverter-Defibrillator
An implantable cardioverter-defibrillator, or ICD, continuously monitors the heart rhythm and can deliver treatment when it detects a dangerous ventricular arrhythmia. It is recommended for people who have survived cardiac arrest or experienced certain sustained ventricular arrhythmias. It may also be considered for selected patients with major risk markers.
An ICD does not treat breathlessness, reduce heart-muscle thickness, or remove an outflow obstruction. Its purpose is to protect against life-threatening rhythms, so the decision requires a careful discussion of benefits, inappropriate shocks, infection, lead complications, and long-term device management.
Exercise and Everyday Life With HCM
Older advice often treated exercise as forbidden territory for everyone with HCM. Current guidance is more individualized. Mild to moderate recreational exercise is encouraged for most patients, and available research has not shown that healthy recreational activity automatically increases ventricular-arrhythmia events.
Participation in vigorous training or competitive sports calls for shared decision-making with an HCM specialist. The discussion should consider symptoms, rhythm history, obstruction, imaging findings, age, the specific sport, emergency planning, and the athlete’s goals. Universal disqualification is no longer considered appropriate.
Practical Lifestyle Considerations
- Stay adequately hydrated unless a clinician has prescribed fluid restriction.
- Ask before using decongestants, stimulants, weight-loss products, or supplements that may raise heart rate or blood pressure.
- Take prescribed medication consistently.
- Avoid abruptly stopping beta-blockers or rhythm medications.
- Report new fainting, worsening breathlessness, swelling, chest pain, or sustained palpitations.
- Discuss alcohol intake, hot-weather activity, heavy lifting, and high-intensity exercise with the care team.
- Keep follow-up appointments even when symptoms are quiet.
Pregnancy is possible for many women with HCM, but preconception counseling is valuable. Care may require coordination among cardiology, maternal-fetal medicine, anesthesia, and genetics specialists. Some medications, including cardiac myosin inhibitors, are unsafe during pregnancy and require specific pregnancy-prevention planning.
Why Family Screening Matters
Parents, siblings, and children of a person with HCM should discuss screening with a healthcare professional. Screening may involve an electrocardiogram, echocardiogram, genetic counseling, and targeted genetic testing when a pathogenic family variant has been identified.
The 2024 American cardiology guideline recommends that family screening begin at any age when appropriate. Follow-up intervals depend on age, symptoms, family history, athletic participation, and genetic findings. Children commonly require reassessment every one to two years, while clinically unaffected adults may be screened every three to five years unless circumstances call for earlier testing.
A negative genetic test in a relative can be reassuring only when the family’s disease-causing variant is already known. A relative should not assume that an inexpensive consumer DNA report has cleared the entire family tree. Clinical genetic counseling is considerably less flashy than an ancestry pie chart, but far more useful here.
Outlook for People With HCM
The outlook for hypertrophic cardiomyopathy has improved as diagnosis, imaging, genetic evaluation, rhythm monitoring, surgery, and medication options have advanced. Many people with HCM have a normal or near-normal lifespan and never experience a catastrophic event. Others need ongoing treatment for obstruction, atrial fibrillation, heart failure, or dangerous ventricular rhythms.
The most useful strategy is neither panic nor denial. It is structured follow-up: understand the individual form of HCM, reassess risk regularly, screen close relatives, remain physically active within an agreed plan, and report changes promptly. HCM may be part of a person’s medical story, but it does not have to write every chapter.
Living With HCM: Common Real-World Experiences
The following examples are composites based on commonly reported patient experiences. They are not descriptions of specific individuals and should not be used to predict another person’s outcome.
Discovering That “Being Out of Shape” Was Not the Whole Story
One common experience begins with subtle limitations. A person who once climbed two flights of stairs without thinking may begin stopping halfway. Because the change develops slowly, it is easy to blame work stress, aging, poor sleep, or an ambitious relationship with takeout food. A routine physical eventually reveals a heart murmur, and an echocardiogram shows thickened heart muscle and an exercise-related outflow obstruction.
The diagnosis can bring two opposite emotions at once: fear about having a genetic heart condition and relief that the unexplained breathlessness finally has a name. Treatment may involve a beta-blocker, hydration strategies, and adjustments to exercise intensity. Improvement is not always dramatic overnight, but ordinary activities may gradually become less exhausting.
Receiving a Diagnosis Without Having Symptoms
Another person may feel completely healthy and learn about HCM only after a sibling or parent is diagnosed. Screening detects mild thickening or a disease-causing genetic variant. This creates an unusual psychological challenge: feeling well while being told that regular cardiac follow-up is important.
At first, appointments may seem unnecessary because there is no pain, dizziness, or shortness of breath. Over time, many people view monitoring differently. Periodic echocardiograms and rhythm checks provide a baseline, identify changes early, and replace vague anxiety with usable information. The goal is not to turn a healthy-feeling person into a full-time patient. It is to keep the person healthy while HCM receives the appropriate amount of attention rather than either all of it or none of it.
Relearning How to Exercise
Exercise conversations can be emotionally loaded, particularly for athletes. A diagnosis may initially feel like an eviction notice from the gym, running trail, basketball court, or competitive team. Modern care increasingly replaces blanket prohibitions with individualized evaluation and shared decision-making.
A recreational runner, for example, may work with an HCM specialist to establish a moderate training plan, pay closer attention to hydration, use a heart-rate target, avoid exercising through warning symptoms, and schedule periodic reassessment. Another patient with significant obstruction or exercise-related fainting may need stricter limitations until treatment improves the underlying problem.
The experience is often less about “exercise versus no exercise” and more about learning which activities are appropriate, how hard to perform them, and which symptoms should end a workout immediately. People sometimes discover new forms of movementcycling, walking, swimming, resistance work with sensible loads, or supervised cardiac rehabilitationthat preserve fitness without turning every session into an audition for an action movie.
Making a Treatment Decision
For someone with severe symptoms despite medication, choosing among a myosin inhibitor, septal myectomy, or alcohol septal ablation can feel overwhelming. Each option has different benefits, limitations, monitoring requirements, and procedural risks. Opinions from an experienced HCM center can be especially valuable.
Patients often describe the decision as easier once the conversation shifts from “Which treatment is universally best?” to “Which treatment best fits my anatomy, symptoms, medical history, priorities, and tolerance for risk?” A person who values avoiding surgery may prefer medication or catheter-based treatment when clinically suitable. Another may choose myectomy because of associated mitral-valve disease or the possibility of durable relief from a severe obstruction.
Managing the Family Conversation
Because HCM can be inherited, diagnosis affects more than one person. Telling siblings or adult children that they should be screened may feel uncomfortable, particularly when family relationships are complicated. Some relatives respond promptly; others avoid testing because they feel healthy or fear what might be discovered.
Genetic counselors can help families communicate accurate information without turning Thanksgiving dinner into an emergency cardiology conference. A simple message often works best: HCM has been identified in the family, screening can detect it before symptoms appear, and early knowledge offers more options for monitoring and prevention.
Living with hypertrophic cardiomyopathy commonly involves periods of uncertainty, but it also involves adaptation. With knowledgeable care, many people return to work, exercise, travel, raise families, and make long-term plans. The condition requires respect, not surrender.
